Mediterranean Diet, Trimethylamine N-oxide (TMAO) and Anti-oxidants in Healthy Adults
TMED
1 other identifier
observational
50
0 countries
N/A
Brief Summary
Trimethylamine N-oxide (TMAO) is a small organic compound naturally present in fish and seefood or generated by the bacterial breakdown of dietary phosphatidylcholine and carnitine-containing foods within the human gut microbiome. Elevated serum TMAO was previously reported to be associated with an elevated risk for cardiovascular events. Aim of this study was to investigate the association between plasma levels of TMAO with the Mediterranean diet in a cohort of healthy adults.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Sep 2016
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 22, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 22, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2017
CompletedFirst Submitted
Initial submission to the registry
February 14, 2017
CompletedFirst Posted
Study publicly available on registry
February 23, 2017
CompletedFebruary 27, 2017
February 1, 2017
3 months
February 14, 2017
February 24, 2017
Conditions
Outcome Measures
Primary Outcomes (2)
Adherence to Mediterranean Diet by Predimed Questionnaire
Validated 14-item tool of adherence to the Mediterranean diet, with three categories of adherence (≤5, low adherence, 6-9, average adherence and ≥10 points, high adherence)
September 2016 to December 2016
Trimethylamine N-oxide plasma levels
ultra high-performance liquid chromatography
September 2016 to December 2016
Secondary Outcomes (1)
cardiovascular risk
September 2016 to December 2016
Eligibility Criteria
Healthy subjects (n=84) aged 21-50 years with a BMI of 20-29.9 kg/m2, chosen among hospital volunteers and employees from the same geographical area. A sample size of n=40 was determined from a power analysis of a within-subject design to detect a 10% difference of plasma TMAO concentration at alfa\<0.05 and β =0.8. Participants were screened by the use of a blood chemistry profile, cell count, and health history questionnaire.
You may qualify if:
- healthy subjects of both gender
You may not qualify if:
- age\>65 years
- \> BMI 30 kg/m2
- vegetarians
- smokers
- gastrointestinal diseases or complaints
- chronic illnesses or other metabolic diseases (including trimethylaminuria)
- abnormal blood chemistry values indicative of organ dysfunctions
- nutritional supplements, antibiotics or probiotics within 2 months of recruitment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Researcher/Adjunct Professor
Study Record Dates
First Submitted
February 14, 2017
First Posted
February 23, 2017
Study Start
September 22, 2016
Primary Completion
December 22, 2016
Study Completion
February 1, 2017
Last Updated
February 27, 2017
Record last verified: 2017-02
Data Sharing
- IPD Sharing
- Will not share